{"timestamp": 1771609071.22218, "value": {"ticker": "ACRS", "company_name": "Aclaris Therapeutics, Inc.", "short_name": "Aclaris Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 348329952, "float_shares": 82009762, "shares_outstanding": 108345239, "short_ratio": 1.7, "short_percent_of_float": 0.054899998, "shares_short": 4989771, "shares_short_prior": 4346454, "insider_percent_held": 0.02957, "institution_percent_held": 0.78587997, "total_cash": 95912000, "total_debt": 2244000, "total_revenue": 15742000, "revenue_growth": -0.241, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": -2.7568302, "operating_margins": -5.16793, "debt_to_equity": 1.868, "current_ratio": 3.925, "book_value": 1.109, "price_to_book": 2.899008, "operating_cashflow": -42920000, "free_cashflow": -58373876, "price": 3.215, "52w_high": 4.89, "52w_low": 1.05, "avg_volume": 1796058, "avg_volume_10d": 969920, "full_time_employees": 61, "audit_risk": 7, "overall_risk": 10}}